Search results
Here's the evidence presented against Donald Trump in his hush money trial
Yahoo News· 3 hours agoBefore the jury begins deliberations in Donald Trump's criminal hush money trial, here are the...
Rite Aid nears deal on post-bankruptcy financing
Reuters· 3 hours agoPharmacy chain Rite Aid is close to reaching a deal on a post-bankruptcy financing package, with a group of lenders preparing to provide interim...
American Picture House Corporation Appoints Mr. Jonathan Sanger as President
Digital Journal· 1 day agoJonathan Sanger as President of the Company. "American Picture House Corp is absolutely delighted to add the esteemed Mr. Jonathan Sanger as President of APHP," said Bannor ...
American Resources Corporation (NASDAQ:AREC) to Participate in the Virtual Investor Closing Bell...
Digital Journal· 2 days agoThese statements are subject to a number of risks and uncertainties, many of which are beyond American Resources Corporation's control. The words "believes ...
“Cash for policy changes": Dems say oil donors funnel millions into Trump legal fee "slush fund"
Salon via Yahoo News· 8 hours ago“Does a corporation that’s determined to stick with business as usual in fossil fuels see the...
Earnings call: American Resources plans spin-offs and expansion By Investing.com
Investing.com· 3 days agoAmerican Resources (NASDAQ:AREC) Corporation (ticker: AREC), in its first quarter 2024 earnings...
Finance and HR Software Stocks Q1 Highlights: BlackLine (NASDAQ:BL)
StockStory via Yahoo Finance· 13 hours agoQuarterly earnings results are a good time to check in on a company’s progress, especially compared...
American Resources (NASDAQ:AREC) Issues Earnings Results, Beats Estimates By $0.03 EPS
ETF DAILY NEWS· 2 days agoAmerican Resources (NASDAQ:AREC – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus ...
Pfizer Tax Practices Targeted by Congress in Wider Pharma Probe
Bloomberg Law· 3 days agoSenate Finance Chair Ron Wyden (D-Ore.) demanded information into the tax practices of Pfizer Inc., expanding his panel’s probe into the profit-shifting practices of US pharmaceutical companies.
HILL TAX BRIEF: Wyden Blasts Pfizer on International Tax Shifts
Bloomberg Law· 3 days agoSenate Finance Committee Chair Ron Wyden (D-Ore.) is expanding his investigation into profit-shifting practices of pharmaceutical companies with a new letter to drug powerhouse Pfizer.